Start Your Search

Tanya Achilles



Author of

  • +

    RF01 - Foundational Methodologies (ID 7)

    • Event: e-Health 2019 Virtual Meeting
    • Type: Rapid Fire Session
    • Track:
    • Presentations: 1
    • Coordinates: 5/27/2019, 10:30 AM - 11:30 AM, Area 5
    • +

      RF01.03 - Removing Barriers to Sharing Drug Information (ID 252)

      Tanya Achilles, Canada Health Infoway; Winnipeg/CA

      • Abstract

      Purpose/Objectives:
      Highlight how the Canadian Drug Dictionary (CCDD) is being used identify drug products in digital health solutions such as e-prescribing, and how it can be used for medication profiles and secondary use such as adverse drug monitoring.


      Methodology/Approach:
      Identified use cases for the CCDD partnered with Health Products and Food Branch of Health Canada (who agreed to own the CCDD) to leverage the Drug Product Database to develop the CCDD content Establish a governance framework to manage content and issues Influence knowledge base vendors to integrate the CCDD within their commercial product Market and communicate the value of the CCDD Improve consistency of drug information within EMR, pharmacy and hospital systems


      Finding/Results:
      The CCDD has been published monthly for over a year. The CCDD content will be complete by March 2019 and include all medicinal products with a Health Canada drug identifier that are being used in Canada. The CCDD has been integrated into at least 3 knowledge base vendor commercial products by January 2019. The CCDD is being used in interoperability projects.


      Conclusion/Implications/Recommendations:
      The CCDD was launched in September 2017 to bridge the gap between systems that don’t speak the same language. For example, electronic medical record (EMR) systems are typically supported by knowledge base vendor databases that provide proprietary coded content that cannot be understood by pharmacy systems that use different knowledge base vendors. When these vendors map their proprietary content to the CCDD, the data can be understood, enabling the sharing of medicinal product data. Doctors can use their EMR to identify the product they wish to prescribe (at the level of detail they wish to use) and the pharmacy can receive, understand and determine the product to dispense. The Canadian Clinical Drug Data Set (CCDD), is receiving tremendous interest from knowledge base vendors who want to integrate it with their commercial products. This will enable more prescribers and pharmacists in Canada to use PrescribeIT™, Canada’s national e-prescribing service and enable other interoperability projects share vital drug information safely and reliably.


      140 Character Summary:
      The CCDD will support more efficient workflows and improved safety in medication management, the national opioid strategy and improve care for individuals.